Study to Evaluate the Efficacy and Safety of TT-00420 in Cholangiocarcinoma
Status:
Not yet recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
This study is an open-label, multicenter study to evaluate the efficacy and safety of
TT-00420 tablet in adult patients with advanced cholangiocarcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
TransThera Biosciences Co., Ltd TransThera Sciences (Nanjing), Inc.